• Abedon ST, 2011: Bacteriophage prehistory: is or is not Hankin, 1896, a phage reference?[J]. Bacteriophage, 1, 174-178. doi: 10.4161/bact.1.3.16591

  • Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM, 2011: Phage Treatment of human infections[J]. Bacteriophage, 1, 66-85. doi: 10.4161/bact.1.2.15845

  • Bernstein D, Fischetti VA. 1997. Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci. US Patent 05604109.

  • Briersa Y, Walmagha M, Van Puyenbroecka V, Cornelissena A, Cenensb W, Aertsenb A, Oliveirac H, Azeredoc J, Verweend G, Pirnayd JP, Miller S, Volckaerta G, Lavignea R, 2014: Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens[J]. MBio, 5, e01379-14-. doi: 10.1128/mBio.01379-14

  • Bruynoghe R, Maisin J, 1921: Essais de thérapeutique au moyen du bactériophage du Staphylocoque[J]. Compt Rend Soc Biol, 85, 1120-1121.

  • Cutter CN, Dorsa WJ, Siragusa GR, 1996: A rapid microbial ATP bioluminescence assay for meat carcasses[J]. Dairy, Food & Environ. San, 16, 726-736.

  • d'Herelle FH. Sur un microbe invisible antagoniste des bacilles dysenteriques. 1917. C R Acad Sci Gen, 165: 373-375. (In French)

  • d'Hérelle F, 1931: Bacteriophagy and recovery from infectious disease[J]. Can Med Assoc J, 24, 619-628.

  • Filatova LYu, Levashov AV, Dmitrieva NF, Eshchina AS, Klyachko NL. 2008. Encapsulation of enzyme lysing group A streptococci to improve its stability. Proc XVIth Int Workshop on Bioencapsulation. Marison I, Poncelet D, Eds., Dublin, Ireland, pp1-4.

  • Fischetti VA, 2005: Bacteriophage lytic enzymes: novel anti-infectives[J]. Trends Microbiol, 13, 491-496. doi: 10.1016/j.tim.2005.08.007

  • Fischetti VA, Gotschlich EC, Bernheimer AW, 1971: Purification and Physical Properties of Group C Streptococcal Phage Associated Lysin[J]. J Exp Med, 133, 1105-1117. doi: 10.1084/jem.133.5.1105

  • Fischetti VA, Loomis L. 1999. Prophylactic and therapeutic treatment of group A streptococcal infection. US Patent 5, 985, 271 A. Spiez, Switzerland.

  • Florin P. 2006. Bacterial Contamination in a Field Hospital. Proc CBMTS-Ⅵ. Spiez, Switzerland.

  • Hasan JAK, S Garg, L Loomis, D Miller, and RR Colwell. 1997. A rapid surface-monitoring method for bacteria employing ATP bioluminescence. Abstr 97th General Meeting of Am. Soc. Microbiol, abstr I-026.

  • Hankin ME, 1896: L'action bactéricide des eaux de la Jumna et du Gange sur le vibrion du choléra[J]. Ann Inst Pasteur (Paris), 10, 511-523.

  • Harper DR, Kutter E. 2008. Bacteriophage: therapeutic use. Encyclopedia of Life Sciences. Chichester, UK: John Wiley & Sons, Ltd. ; pp1-7.

  • Ho K, 2001: Bacteriophage therapy for bacterial infections[J]. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med, 44, 1-16.

  • Hoopes JT, Stark CJ, Kim HA, Sussman DJ, Donovan DM, Nelson DC, 2009: Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi[J]. Appl Environ Microbiol, 75, 1388-1394. doi: 10.1128/AEM.02195-08

  • Krause RM, 1958: Studies on the Bacteriophages of Hemolytic Streptococci[J]. J Exp Med, 108, 803-821. doi: 10.1084/jem.108.6.803

  • Klyachko NL, Dmitrieva NF, Eshchina AS, Ignatenko OV, Filatova LY, Rainina EI, Kazarov AK, Levashov AV, 2008: Bacteriophage enzyme for the prevention and treatment of bacterial infections: stability and stabilization of the enzyme lysing Streptococcus pyogenes cells[J]. Russ J Bioorganic Chem, 34, 375-379. doi: 10.1134/S1068162008030217

  • Maxted WR, 1957: The Active Agent in Nascent Phage Lysis of Streptococci[J]. J Gen Micro, 16, 585-595.

  • Nelson D, Loomis L, Fischetti VA, 2001: Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using bacteriophage lytic enzyme[J]. Proc Natl Acad Sci U S A, 98, 4107-4112. doi: 10.1073/pnas.061038398

  • Roach DR, Khatibi PA, Bischoff KM, Hughes SR and Donovan DM, 2013: Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations[J]. Biotechnol Biofuels, 6, 20-. doi: 10.1186/1754-6834-6-20

  • Schmelcher M, Powella A, Beckera S, Campb M, Donovan D, 2012: Chimeric phage lysins act synergistically with lysostaphin to kill mastitis -causing Staphylococcus aureus in murine mammary glands[J]. Appl Environ Microbiol, 78, 2297-2305. doi: 10.1128/AEM.07050-11

  • Schuch R, Nelso D, Fischetti V, 2002: A bacteriolytic agent that detects and kills Bacillus anthracis[J]. Nature, 418, 884-889. doi: 10.1038/nature01026

  • Siragusa GR, Cutter CN, Dorsa WJ, Koohmaraie M, 1995: Use of a rapid microbial ATP bio-luminescence assay to detect contamination on beef and pork carcasses[J]. J Food Prot, 58, 770-775. doi: 10.4315/0362-028X-58.7.770

  • Siragusa GR, Dorsa WJ, Cutter CN, Perino LJ, Koohmaraie M, 1996: Use of a newly developed rapid microbial ATP bioluminescence assay to detect microbial contamination on poultry carcasses[J]. J Biolumin Chemilumin, 11, 297-301. doi: 10.1002/(ISSN)1099-1271

  • Stopa PJ, Tieman D, Coon PA, Milton MM, Paterno D, 1999: Detection of biological aerosols by luminescence techniques[J]. Field Anal Chem Technol, 3, 283-290. doi: 10.1002/(ISSN)1520-6521

  • Sulakvelidze A, Barrow P. 2005. Phage therapy in animals and agribusiness. In: Bacteriophages: Biology and Applications. Kutter E, Sulakvelidze. Boca Raton: CRC Press. pp335-380.

  • Summers WC, 2001: Bacteriophage therapy[J]. Annu Rev Microbiol, 55, 437-451. doi: 10.1146/annurev.micro.55.1.437

  • Trudil D. 2002. Use of phage associated lytic enzymes for rapid detection of bacterial contaminants (priority date 1999). US Patent 6395504.

  • Trudil D, Rainina E. 2006. Use of Lytic Enzymes for Microbiological Decontamination of Sensitive Facilities. Proc 5TH SISPAT, Singapore.

  • Twort FW, 1915: An investigation on the nature of ultramicroscopic viruses[J]. Lancet, 186, 1241-1246. doi: 10.1016/S0140-6736(01)20383-3

  • Yang H, Zhang Y, Yu J, Huang Y, Zhang XE, Wei H, 2014: Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo[J]. Antimicrob Agents Ch, 58, 536-542. doi: 10.1128/AAC.01793-13